
Ministers take note: now is the moment to fight to keep AstraZeneca’s listing in London | Nils Pratley
It was an opportunity for Sir Pascal Soriot, as chief executive of AstraZeneca, the UK’s finest pharmaceutical firm, to kill the story stone dead if he wished. Does he want to move the company’s stock market listing to the US, as reported by the Times a …